Yamanaga K - Search Results

1

Effect of the ALDH2 Variant on the Prevalence of Atrial Fibrillation in Habitual Drinkers.

Yamashita T, Arima Y, Hoshiyama T, Tabata N, Sueta D, Kawahara Y, Ito M, Kanazawa H, Ishii M, Yamanaga K, Hanatani S, Takashio S, Araki S, Suzuki S, Yamamoto E, Kaikita K, Oniki K, Saruwatari J, Matsushita K, Tsujita K. Yamashita T, et al. Among authors: yamanaga k. JACC Asia. 2022 Jan 18;2(1):62-70. doi: 10.1016/j.jacasi.2021.10.009. eCollection 2022 Feb. JACC Asia. 2022. PMID: 36340257 Free PMC article.

2

AE0047-mediated calcium channel blocking in vascular smooth muscles.

Yamanaga K, Shinyama H, Akira T, Iwamoto M, Uchida T, Nakamura N, Kagitani Y. Yamanaga K, et al. Gen Pharmacol. 1997 Sep;29(3):337-43. doi: 10.1016/s0306-3623(96)00515-0. Gen Pharmacol. 1997. PMID: 9378237

3

[Antihypertensive effects of a novel calcium antagonist, AE0047, in various hypertensive models].

Kido H, Nishikawa M, Hayashi K, Kubo Y, Ohtaki Y, Fujino Y, Egi Y, Ebisu H, Inoue S, Yamanaga K, Uchida T, Nakamura N. Kido H, et al. Among authors: yamanaga k. Nihon Yakurigaku Zasshi. 1997 Jun;109(6):279-89. doi: 10.1254/fpj.109.279. Nihon Yakurigaku Zasshi. 1997. PMID: 9253775 Japanese.

4

Torasemide, but not frusemide, increases intracellular cAMP and cGMP content in the aorta of the renal hypertensive rat.

Yamanaga K, Uchida T, Kido H, Hayashi K, Watanabe M. Yamanaga K, et al. J Pharm Pharmacol. 1992 Jan;44(1):64-5. doi: 10.1111/j.2042-7158.1992.tb14367.x. J Pharm Pharmacol. 1992. PMID: 1350633

5

Diuretic and vasodilating actions of torasemide.

Uchida T, Yamanaga K, Kido H, Ohtaki Y, Watanabe M. Uchida T, et al. Among authors: yamanaga k. Cardiology. 1994;84 Suppl 2:14-7. doi: 10.1159/000176452. Cardiology. 1994. PMID: 7954537

6

Anti-aldosteronergic effect of torasemide.

Uchida T, Yamanaga K, Nishikawa M, Ohtaki Y, Kido H, Watanabe M. Uchida T, et al. Among authors: yamanaga k. Eur J Pharmacol. 1991 Nov 26;205(2):145-50. doi: 10.1016/0014-2999(91)90812-5. Eur J Pharmacol. 1991. PMID: 1812004

7

Aging decreases the production of PGI2 in rat aortic endothelial cells.

Nakajima M, Hashimoto M, Wang F, Yamanaga K, Nakamura N, Uchida T, Yamanouchi K. Nakajima M, et al. Among authors: yamanaga k. Exp Gerontol. 1997 Nov-Dec;32(6):685-93. doi: 10.1016/s0531-5565(97)00089-2. Exp Gerontol. 1997. PMID: 9785094

8

A novel loop diuretic, torasemide, inhibits thromboxane A2-induced contraction in the isolated canine coronary artery.

Uchida T, Kido H, Yamanaga K, Okita M, Watanabe M. Uchida T, et al. Among authors: yamanaga k. Prostaglandins Leukot Essent Fatty Acids. 1992 Feb;45(2):121-4. doi: 10.1016/0952-3278(92)90227-a. Prostaglandins Leukot Essent Fatty Acids. 1992. PMID: 1561230

9

Calcium channel blocking and vasodilating actions of the novel dihydropyridine derivative AE0047.

Nishikawa M, Gohda M, Shinyama H, Matzno S, Yamanaga K, Kido H, Nakamura N. Nishikawa M, et al. Among authors: yamanaga k. Clin Exp Pharmacol Physiol. 1998 May;25(5):347-54. doi: 10.1111/j.1440-1681.1998.tb02362.x. Clin Exp Pharmacol Physiol. 1998. PMID: 9612662

10

Antithrombin III prevents blood pressure elevation and proteinuria induced by high salt intake in pregnant stroke-prone spontaneously hypertensive rats.

Shinyama H, Yamanaga K, Akira T, Uchida T, Yaguchi M, Watanabe M, Kagitani Y. Shinyama H, et al. Among authors: yamanaga k. Biol Pharm Bull. 1996 Jun;19(6):819-23. doi: 10.1248/bpb.19.819. Biol Pharm Bull. 1996. PMID: 8799479

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

90 results

Search Page